Grafting neurons derived from a monkey's own stem cells reversed the debilitating and mental health symptoms associated with Parkinson's disease. The treatment shows promise for alleviating the symptoms of Parkinson's in humans.
Hematopoietic stem cell transplantation reversed neuromyelitis optica. Five years following transplantation, only 2 of twelve patients had relapsed.
Researchers have developed a new method to transplant neural stem cells into mice without the need for lifelong anti-rejection medications.
Researchers report transplanting altered neural stem cells into the brains of mice genetically engineered to exhibit symptoms of ALS, delayed the progression of the disease and extended lifespan.
Researchers reveal that a year after receiving autologous haematopoietic stem cell transplantation for relapse remitting multiple sclerosis, almost all of the patients showed no signs of the disease and the level of their disability was significantly improved.
In a groundbreaking study, researchers use engineered tissue derived from human stem cells to treat rats with paraplegia following spinal cord injury. The transplanted cells allowed the rats to regain sensory perception, improve mobility and helped with spinal cord healing.
According to researchers, bone marrow stem cell transplants helped repair damage to the blood spinal cord barrier in mouse models of ALS. This helped improve motor functions and nervous system conditions.
A new treatment for multiple sclerosis prevents symptoms of the disease from worsening for up to five years in 46% of patients treated, a new study reports.
Researchers report they have successfully transplanted retinal pigment cells derived from stem cells without rejection or the need of immunosuppressant drugs.
According to a new study, rats with hypopituitarism received pituitary cell transplants, which promoted normal hormone release.
Researchers report a procedure that wipes out the immune system and then regenerates a new one using stem cells may effectively eliminate all signs of neuroinflammation in people with early, aggressive MS.
By transplanting healthy glial cells, researchers have succeeded in reducing the symptoms and slowing the progression of Huntington's disease in mice.
